Advertorial

Top MD Warns: Take This 1 “Acid” Before Bed For Burning Neuropathy Feet?

Dr. Alan Voss, MD
Written by Dr. Alan Voss, MD
Pain Medicine · Medical Director, Meridian Nerve Research
A woman sitting on the edge of her bed at night holding her burning foot

I'm about to piss off every neurologist, pain-management doctor, and supplement company in America.

Because what I'm about to show you could cost them a fortune.

But I don't care anymore.

After reading what my patient Delores wrote in all caps on her follow-up survey — “I CANNOT DO ANOTHER NIGHT OF THIS”

After watching her describe lying awake at 2:00 in the morning with both feet feeling like someone was holding a lit match under the arches... not moving... not making a sound... because she'd already woken her husband up three times that week...

After watching the system put her on gabapentin that added 30 pounds and turned her into a fog... then Lyrica... then a $2,400 nerve block that wore off before she got home from the clinic... and then tell her she'd have to “learn to live with it”...

I knew we had failed her.

So I went and did something my colleagues are not going to like.

And if you're reading this with feet that burn so badly you can't stand a sock... toes that tingle like fire ants under the skin... or you're the person hanging both feet off the end of the bed at 2 A.M. because even the sheet feels like sandpaper...

The next 6 minutes may be the most important thing you read this year.

My name is Dr. Alan Voss. I've been a licensed pain specialist for 14 years. I serve as Medical Director of Meridian Nerve Research, an independent group that looks at the treatments the drug industry has no financial reason to look at.

And I'm going to show you the documented reason millions of American diabetics are still burning at night — while the people treating them bill for it, year after year.

But first, let me tell you about the night that changed how I practice.

The Night Everything Changed

A doctor at his desk late at night reading patient surveys

I was in my office late on a Thursday. Going through the week's follow-up surveys.

Most were the usual. “Gabapentin takes the edge off.” “Still burning, but managing.”

Then I got to Delores's. And my stomach dropped.

She had written it in capital letters and pressed hard enough to tear the paper:

“I CANNOT DO ANOTHER NIGHT OF THIS.”

Not “the pain is worse.” Not “I'm having trouble sleeping.”

She described waking at 2:00 A.M. with both feet on fire. The kind of burning that makes you want to scream into a pillow — except you don't, because your husband has to be up at six and you've already woken him three times this week.

So you lie there. Jaw clenched. Watching the ceiling. Doing arithmetic on how many hours until it's light.

She'd stopped wearing closed shoes. The pressure across the top of her foot was unbearable.

She'd stopped walking barefoot on tile, because a flat clean floor felt like broken glass.

Some nights she slept in the recliner, because the weight of a bedsheet across her toes was enough to wake her up.

She was 69. And she told me she had started to feel like her own feet had turned against her.

Not because she'd given up. Because she could not picture another fifteen years of it.

That's the part that got me. Because here's the thing...

A man awake at night with a fan pointed at his bare feet
The fan at the end of the bed isn't a preference. It's a coping strategy millions of people invented independently.

Delores had done everything she was told. Medications. Physical therapy. Nerve blocks. Tighter blood-sugar control. A B-vitamin off the pharmacy shelf. All of it.

Her neurologist? Gabapentin. She gained 30 pounds and described feeling “switched off” all day. Still woke up burning. Then Lyrica. Same story, different side effects.

Her pain doctor? Three nerve blocks in fourteen months. $2,400 a piece. Relief measured in days.

Her endocrinologist? Adjusted her medications and told her burning feet are simply part of having diabetes for twenty years.

Learn to live with it.

As though she was supposed to make peace with nightly torture. While everyone kept billing her insurance.

I sat with that survey for a long time. And something in me changed.

Because I had personally referred dozens of patients into exactly that pipeline. And I had never once questioned it.

The Mind-Blowing Discovery

A doctor buried in medical journals and research papers

For the next four months I lived like a man possessed.

I read every paper on diabetic peripheral neuropathy I could pull. I called researchers. I paid out of my own pocket for journal access and database subscriptions my hospital wouldn't cover. I read trial protocols on planes.

My wife thought I'd lost the thread. Maybe I had.

And what I found made me want to call every patient I'd ever handed a gabapentin prescription to and apologize.

Here's the first thing nobody tells you:

Your feet are not burning because your nerves are damaged beyond help.

They're burning because nerve fibers that are still alive are being attacked from two directions at once — and nothing you have been given addresses either direction.

I know that's not what you were told. You were probably told the damage is permanent, the nerves are “degenerating,” and the only thing left is to manage the pain.

But answer me this.

Why do enormous numbers of people over 55 have measurable nerve changes on testing... and feel nothing at all?

And why do others, with the same test results and the same A1C, spend every night in agony?

Because the presence of nerve damage isn't what generates the burning. What generates it is the process that's still actively running.

And that process has been documented for decades. There is simply no money in the thing that addresses it.

The Real Root Cause Of Burning Nerve Pain

Free radicals burning inside a nerve fibre while its capillaries wither

Here is what chronic high blood sugar actually does to the nerves in your feet. And it does both of these things at the same time, which is the part that matters.

One: it floods those nerve fibers with reactive oxygen species — free radicals. An oxidative fire, burning inside the fiber itself.

Two: it damages the microscopic capillaries that feed those same fibers. So while the fiber is burning, its oxygen and nutrient supply is being cut off.

Burned from the inside. Starved from the outside. Researchers call the result oxidative nerve starvation.

Picture the power cord on an old lamp.

Inside is a copper wire carrying the signal. Wrapped around it is a thick rubber coating. When the coating is intact, the signal runs clean and your feet feel like feet.

But oxidative stress frays that coating from the inside while the blood supply feeding the repair crew gets choked off. The coating thins. The wire underneath gets exposed.

And an exposed wire doesn't go quiet. It sparks. It shorts. It fires when nothing is touching it.

That is the burning at 2 A.M. when the room is cool and nothing is on your feet.

That is the pins and needles that never entirely stop — bare nerve endings misfiring with nothing to quiet them.

That is the sensation of walking on broken glass across a floor that is perfectly smooth. A live wire sending a false alarm with every step.

And it explains the sequence patients describe but almost never get explained to them: why the tingling comes first and the numbness follows (the smallest fibers fail first, in order), and why it is always worst at night (oxidative load accumulates across the day).

Now here is the part that made me angry.

Gabapentin does not touch either mechanism.

It dampens the pain signal traveling up the nerve. That's it. Clinical reviews state it about as plainly as medicine ever states anything: these drugs “do not affect the underlying disease pathogenesis.”

It's a smoke alarm.

Pulling the battery out of a screaming smoke alarm absolutely stops the noise. It does not do one single thing about the fire in the wall.

That is the entire difference between silencing a pain signal and reaching the oxidative damage that is causing it.

And I want you to see the receipt on this, because it's worse than incompetence.

A 1999 journal page with the gabapentin conclusion highlighted
Published in 1999. Indexed. Available to any physician who went looking.

In 1999, a placebo-controlled trial of gabapentin for painful diabetic neuropathy was published in a peer-reviewed neurology journal. Forty patients. The trial was run with support from Parke-Davis — the company that made the drug.

Its published conclusion, word for word:

J Neurol Neurosurg Psychiatry 1999;66(2):251–252“gabapentin is probably ineffective or only minimally effective for the treatment of painful diabetic neuropathy at a dosage of 900 mg per day.”

The numbers behind it weren't close. 17 of 40 patients (43%) reported moderate or excellent relief on the drug. On the placebo — a sugar pill — 9 of 40 (23%) reported the same thing.

That gap is the entire clinical case for what's in your medicine cabinet right now.

Five years later, on May 13, 2004, the Department of Justice announced that Warner-Lambert had agreed to plead guilty to two counts of violating the Food, Drug & Cosmetic Act and to pay a $430 million settlement, including what DOJ described at the time as the second-largest criminal fine ever imposed in a health-care fraud prosecution.

Court records in the litigation that followed showed the company's own internal experts had written that the evidence was “not convincing to support a broad neuropathic pain claim.”

By the California Attorney General's account that same month, about 90 percent of prescriptions for the drug were off-label. Nine out of ten.

A 2004 newspaper clipping reporting the $430 million settlement
It was in the papers in 2004. It never made it into the exam room.

I'll be straight with you, because I'm not interested in replacing one oversell with another: the drug is not inert. Some people genuinely do get relief from it. A 2017 Cochrane review found it helps some patients with diabetic neuropathy — while flagging that high-quality evidence was lacking.

But that is a thin, contested, modest effect. Promoted at industrial scale. For a condition its own funded trial said it probably didn't help.

And the whole time, there was something else.

The 60-Year-Old Answer Hiding In Plain Sight

A German pharmacist placing a carton of alpha-lipoic acid on the counter
In German pharmacies this is a routine dispense. Reimbursed. For sixty years.

This is the sentence that ended four months of reading for me. It is not from an activist or a supplement company. It's from a 2012 meta-analysis in a peer-reviewed endocrinology journal:

Int J Endocrinol 2012 (PMID 22331979)“In Germany, alpha lipoic acid is approved for the treatment of diabetic neuropathic pain and covered by health insurance companies, but use has not been widely adopted elsewhere.”

Read that again. Approved. Reimbursed. Since the 1960s. In a G7 country with one of the most conservative medical regulators on earth.

Alpha-lipoic acid — thioctic acid — was isolated in 1951 and in clinical use by the late fifties. While American patients were being funneled toward a patented anticonvulsant, this was running in parallel:

1995 — ALADIN. Diabetologia, 328 patients. Symptom scores in the feet fell 63.5% on 600 mg versus 38.4% on placebo (p<0.001). Given intravenously.

2006 — SYDNEY 2. Diabetes Care, 181 patients, oral dosing. Dr. Dan Ziegler's team concluded 600 mg once daily gave the optimum risk-to-benefit ratio. Higher doses were no better and caused more stomach upset. More was not more.

2011 — NATHAN 1. Diabetes Care, 460 patients, four years on oral 600 mg. It missed its primary composite endpoint, but improved several measures and was well tolerated across four years.

2012 — pooled analysis. Across trials, a symptom-score reduction of −2.26 favoring alpha-lipoic acid — measured on the four things that keep you awake: stabbing pain, burning, paresthesia, numbness.

Four randomized trials. Over a thousand patients. Three decades. A named principal investigator with an international reputation.

And in the United States: nothing. No detail visits. No dosing card. No lunch-and-learn. Silence.

So I went looking for the conspiracy. What I found was an accounting problem.

You cannot patent a naturally occurring molecule. Running a compound through FDA approval costs on the order of a billion dollars, and no company on earth will spend that on something a competitor can sell the next morning.

No patent, no approval. No approval, no sales force. No sales force, no lunches, no samples, no continuing-education module, no laminated card in your doctor's drawer.

So the prescription pad defaults to the drug that had all of those things. Not because anybody decided it worked better. Because it was the one being promoted.

Which means the silence was never evidence against it.

Absence of marketing is not absence of evidence. Those are two completely different things — and for twenty years, one was allowed to pass for the other.

Here's what I learned about applying it. To actually get at burning nerve pain, you have to do three things at once:

1) Get an antioxidant to where the fire actually is. Inside peripheral nerve tissue, across the blood-nerve barrier. Most antioxidants physically cannot get there. If it can't reach the tissue, nothing else matters.

2) Work in both the watery and the fatty parts of the nerve. The cell body is water. The protective sheath is fat. Vitamin C only works in one. Vitamin E only works in the other. Cover one and you've done half a job.

3) Deliver the amount the research actually used. 600 mg. Not 150. Not 300 with a second bottle sold separately.

Miss any one of those three and you will conclude, entirely reasonably, that nothing works.

That's why the B-vitamin off the pharmacy shelf didn't do it. That's why the nerve block didn't do it. That's why the “nerve support” bottle with fourteen ingredients on the label didn't do it.

And it is why the thing that did work, when I finally applied it properly, wasn't a stack of fourteen ingredients at all.

This Simple Breakthrough Is Pissing Off An Entire Industry

An older man standing comfortably at his stove cooking Sunday dinner

Word travels fast in a hospital.

My colleague Wendell — a physical therapist I'd worked alongside for eleven years — caught me in the break room one evening.

“Whatever you did for Delores. I need it.”

Wendell was 66. Type 2 for fifteen years. A man who genuinely never complained about anything.

But neuropathy had worn him down. His feet burned so badly at night he'd stopped sleeping in his own bed — every night in a recliner with his feet up, the only arrangement that got the burning down to something he could sit with.

The part that actually hurt him wasn't the pain. For thirty years Wendell had cooked Sunday dinner for his family. Every week. It was his thing. It was how he showed up for people.

And standing on a hard kitchen floor for more than ten minutes had become impossible. The burning would climb until he had to sit. He'd been ordering in for seven months.

He'd tried three medications. Nerve blocks. A TENS unit. Two prescription creams. Nothing held for more than an hour.

I walked him through the same three things. The right molecule, the right form, the right dose — every night, no skipping.

Five weeks later he came and found me at my desk. Unannounced. His eyes were red.

Wendell, 66“I made Sunday dinner. Stood at that stove two hours and never sat down. Alan — the floor just felt like a floor.”

He broke down in my doorway. Not from pain. From relief.

Inside three months I had people finding my office. Retired teachers whose feet burned too badly to walk to the mailbox. Diabetics who hadn't worn a sandal in six years because the strap was unbearable. Grandparents who couldn't take the grandkids to the park because every step felt like hot gravel.

Not everyone. I want to be honest with you about that — this is not a light switch and it is not a miracle. But enough of them, and consistently enough, that I could no longer justify sending people down the old pipeline first.

And that is when the trouble started.

When You Mess With A $90 Billion Hamster Wheel

Cease and desist letters on a desk

First came the friendly version.

A pain-management physician I'd known over a decade took me aside at a conference. “Alan, what you're doing makes the rest of us look bad. Patients are coming in asking why nobody told them. You should stop before somebody gets hurt.”

Translation: stop before somebody stops paying.

Then came the letters. Three firms, all representing “concerned parties.” All suggesting I was practicing outside my scope by discussing published research with my own patients.

The one that actually stung? A device rep I'd worked with for six years — the guy who bought me lunch every month — stopped returning calls. “Corporate moved me to other accounts. Nothing personal.”

Nothing personal. Right.

Here's the arithmetic that explains all of it. A patient managed the standard way is worth thousands of dollars a year, every year, indefinitely. Monthly visits. Monthly prescriptions. Periodic injections. Escalating procedures when those stop working.

A patient who sleeps through the night on something that costs less than a co-pay is worth nothing to anybody.

What I'd landed on was a problem for them because it was:

• Aimed at the oxidative process itself, not the alarm bell
• Available without an appointment, a referral, or a prior authorization
• Cheaper than a single nerve-block co-pay
• Something a person could do at home, forever, without them

What they didn't count on is that I'd already found a small group of people willing to make it properly. People who'd watched their own parents go through this.

Three Jobs. One Molecule. Nothing Else In The Pouch.

Noverly R-Alpha Lipoic Acid on a bedside nightstand

It's called Noverly R-Alpha Lipoic Acid. 600 mg per serving. Pure R-form. In a coconut-oil softgel.

And now I have to tell you the thing that separates it from every bottle on the shelf — because it is not a longer ingredient list.

Most “nerve support” formulas brag about having twelve actives. Noverly has one.

That is deliberate, and once you understand why, you'll never look at a fourteen-ingredient label the same way again.

Because alpha-lipoic acid is not one of several things that help a little. It is the one molecule that does all three jobs at once — and burying it in a blend is how you end up with too little of it to matter.

Job 1: It Crosses The Blood-Nerve Barrier

Your peripheral nerves sit behind a protective shield that blocks most molecules from getting in. This is the reason so many antioxidants do nothing for nerve pain no matter how much you take — they never arrive.

Alpha-lipoic acid crosses it. It penetrates nerve tissue and gets into the mitochondria, where it also functions as a cofactor in converting glucose into energy. It shows up where the fire is.

Everything else is irrelevant if this part fails. Almost nothing else passes this door.

Job 2: It Works In Water AND Fat

This is the property almost nobody explains, and it's the reason it fits this particular problem so well.

A nerve fiber has two very different environments. The cell body is watery. The protective sheath wrapped around it is fatty. Damage happens in both.

Vitamin C is water-soluble — it works in the first and can't help in the second. Vitamin E is fat-soluble — the reverse. Nearly every antioxidant is one or the other.

Alpha-lipoic acid is both. It is sometimes called the universal antioxidant for exactly this reason. Inside the watery cell body and along the fatty sheath, in one molecule. Which is why one done properly beats twelve done partially.

Job 3: It Recharges The Antioxidants You Already Have

The third job is the one that compounds. Alpha-lipoic acid regenerates other antioxidants your body is already running on — vitamins C and E, glutathione, CoQ10 — putting them back into service after they've been spent.

So it isn't just adding one more soldier to the line. It's resupplying the ones already there.

Three jobs. One molecule. Which brings me to the part that made me genuinely angry — and the reason so many people reading this have already tried alpha-lipoic acid and felt absolutely nothing.

Now The Part That Will Make You Angry: You Were Sold Half A Molecule

Two keys on a ring, one cut and one a smooth blank
Two keys, one ring. Only one of them was ever cut to open anything.

If you've already tried alpha-lipoic acid and it did nothing, you are reading this with your arms folded. You should be. Let me explain what happened, because it is a manufacturing decision and it is not printed on the front of any bottle.

Alpha-lipoic acid has a single chiral center. That means it exists in two mirror-image forms: R and S.

Only the R-form occurs in nature and binds the mitochondrial enzymes it's supposed to work with. The S-form is a synthetic byproduct — it exists because the cheap way of manufacturing the molecule produces both, and separating them costs money.

Nearly all alpha-lipoic acid sold in America is racemic: a 50/50 blend.

So when you bought a “600 mg” bottle of ALA:

Roughly 300 mg was the isomer your nerve cells can actually use. The other 300 mg was its mirror image.

Pharmacokinetic work has found plasma levels of the R-isomer run around 1.5× higher than the S after a dose — and there is evidence the S-form competes with R for absorption. It isn't just inert filler. It can get in the way at the door.

Producing the R-form pure costs five to seven times as much per milligram. Which is exactly why almost nobody bothers.

Two keys on a ring. One is cut. One is a smooth blank that opens nothing and jams the lock while it's in there.

You didn't fail alpha-lipoic acid. You were handed the blank.

And I need to be precise here, because precision is the whole reason you should trust anything else on this page. So here are the three limits, stated plainly. Hold anyone selling you this to every one of them.

One: the landmark trials used racemic ALA, not the pure R-form. ALADIN, SYDNEY 2 and NATHAN 1 all ran on the racemic mixture at 600 mg. Anybody telling you pure R-ALA is “clinically proven” for neuropathy is overselling it. What's defensible is narrower and more interesting: 600 mg is the dose the research landed on, and R is the active half of the molecule that was studied — delivered without the half that isn't.

Two: the strongest results came from IV infusions. In German clinics much of this was given intravenously, and that's where the effect sizes are largest. The 2012 meta-analysis says out loud that for oral dosing, whether the improvement is clinically relevant is “unclear.” A softgel is not an infusion and I won't pretend otherwise.

Three: it is a supplement, not a drug. It does not treat, cure or reverse neuropathy, and no honest person will tell you it will. What it is, is antioxidant support aimed squarely at the oxidative side of the problem — the side the pill in your cabinet was never built to reach.

I would rather you trust the parts of this that are solid than swallow a version where every single thing sounds perfect. You have already been sold one of those.

Here's Exactly What Happens — Week By Week

A woman standing barefoot on her kitchen floor looking down at her feet

Now, I have to set an expectation, and it's the opposite of what the cream-and-patch people will tell you.

This is not a fifteen-minute product. Nothing you rub on or swallow reverses months of oxidative load in an afternoon, and anybody promising you that is selling you a sensation, not a change.

What I've watched, over and over, is a build. It is gradual, it is unglamorous, and honestly — that's the part that convinced me it was real. Here's the sequence, as patients describe it:

Weeks 1–2 — the “did I imagine that?” phase

Almost nothing dramatic. Most people report one extra hour before the burning wakes them, or getting to sleep a little faster. It is subtle enough that you won't trust it, and you'll probably talk yourself out of it. Write it down anyway. Nearly everyone underestimates this stage in hindsight.

Weeks 3–4 — the sheet goes back on

This is the milestone people actually remember. They wake up and realize both feet have been under the covers all night. Not hanging off the edge. Not out from under the blanket with a fan on them. Just under the sheet, like a normal person's feet, for seven or eight hours.

The reports get more specific here too — the electric jabs spacing out, the constant background buzz dropping to something you have to go looking for.

Weeks 5–6 — the first step stops being a decision

For years, the first step out of bed in the morning has been something you brace for. You sit on the edge. You put one foot down carefully. You wait to find out what kind of day it's going to be.

What people describe around week five is that they simply stood up and walked. And only noticed later that they hadn't braced. Around here you start hearing about the grocery store — walking the whole store and only remembering their feet in the parking lot.

Not numb. Not sedated. Not chemically blocked while the underlying damage keeps going.

Just quieter. Which, if your feet have been screaming for six years, is not a small word.

And most people look down at some point in week five or six, and press a bare foot flat against the floor, and stop. Because they had forgotten what their own feet were supposed to feel like.

APPLY DISCOUNT & CHECK AVAILABILITYPure R-Form · 600 mg · One Ingredient

50% OFF + Buy 1, Get 1 Free — backed by a 90-day money-back guarantee

The Results That Have Pain Clinics Scrambling

An older man walking comfortably through a grocery store aisle
The milestone nobody puts on a pain scale: walking the whole store and forgetting about your feet.

To date, 10,000 people have used Noverly's pure R-form for burning, tingling and numb feet.

I'm not going to give you a fake percentage. What I'll tell you is what shows up in the reviews over and over, in the same order I described above — and that the refund rate sits at 0.4%, which for a product this avatar has every reason to distrust tells you more than any statistic I could construct.

4.8
★★★★★
Based on 1,842 verified customer reviews
Curtis P.
Curtis P., 66
✓ Verified Buyer
★★★★★
“Nine years on gabapentin. Nine. Nobody ever once said the word ‘isomer’ to me. I'm not angry about the supplement — I'm angry about the nine years.”
Marlene D.
Marlene D., 70
✓ Verified Buyer
★★★★★
“I'd tried the cheap kind twice and written the whole thing off. Turns out I'd been buying half a molecule. The fan has been off for three weeks.”
Eugene R.
Eugene R., 63
✓ Verified Buyer
★★★★★
“What got me wasn't the promise. It was that this was the first page that told me what it couldn't do. So I believed the rest of it.”
Dr. Voss
From my own inbox
✓ Patient report
★★★★★
“Slept with the blanket over my feet last night. First time since 2019. I sat up and cried about it, which my wife found hilarious.”
Delores, 69 — the survey that started this“I've tried everything for these feet. Pills, creams, the blocks. Nothing held more than a couple of days. This built up slowly, which honestly made me trust it more. Six weeks in I walked barefoot across my own kitchen floor and just stood there in the middle of it. My daughter asked what I was doing. I said I forgot what a floor felt like.”

The Price That Is Causing Medical Industry Panic

A stack of medical bills, statements and a prescription bottle on a kitchen table

Let me show you what “managing” burning nerve pain actually costs in this country.

The Pain Management + Medication Route
  • Monthly clinic visits: $200–300
  • Prescription nerve medications: $350–600/month (branded, before insurance)
  • Nerve block injections: $2,000–3,500 each, 3–6 per year
Annual total: $8,400–$18,200 — plus the fog, the weight, and the fact that the trial behind the first-line drug said it probably didn't work.
The Escalation Route
  • Consultation and imaging: $3,000+
  • Ablation procedures: $3,500–5,000 each, usually more than one
  • Spinal cord stimulator implant: $30,000–$50,000, with weeks of recovery
Total: five figures and up — for relief measured in months, after which you are back at the start.

The industry has no reason to dislike any of this. You come back. Failed procedure, next procedure. Temporary relief, lifetime customer.

Now here's what a month of pure R-form at the studied dose costs.

Less than a single co-pay. Less than one month of a branded nerve medication. Less than you'd spend on takeout in a week.

And it is the only line on this page where the risk doesn't sit with you.

The 50% Off “Middle Finger” To The Establishment

Remember the letters? The conference conversation? The rep who stopped calling?

Here's my answer to all of it.

Right now Noverly's pure R-form is 50% off, plus Buy 1, Get 1 Free.

Why would I push for that? Because every person who gets a full night's sleep is walking evidence that the standard pipeline failed them. Because I want thousands of those people out there before anybody manages to make this inconvenient to talk about.

And because I'm angry. This is the most constructive version of angry I've got.

But Here's The Catch (And It's A Big One)

⚠ This is a supply problem, not a marketing gimmick.

Pure R-form costs five to seven times more per milligram to produce than the racemic version nearly every other brand uses. That is the entire reason the shelf is full of the cheap blend. Noverly is sold direct, batches are limited, and at the time of writing there are 2,184 units at this price. I can't promise how long that lasts and I'm not going to invent a countdown for you.

What I will say is this. Every night you spend deciding is another night of the thing you already know too well. The 2 A.M. arithmetic. The foot off the edge of the bed. The fan.

You've done enough of those.

My Personal 90-Day “Sleep Through The Night Or It's Free” Guarantee

Look. I understand the position you're in. You've been burned — literally and financially. You've bought things that promised the world. You've trusted people in white coats who let you down. I'm asking you to trust another one.

So I'm not going to ask you to take my word for any of it.

Take it for 90 days. Every single night. Give it the full run, because as I said, the third and fifth weeks are where this declares itself — a two-week trial tells you nothing.

And if you don't get to a morning where you look down and realize you slept with the sheet over your feet and didn't think about them once... send it back for every penny.

Empty pouch included. No forms. No store credit. No hoops.

Ninety days is not an accident, by the way. It's roughly the window in which the reported sequence plays out. I have no interest in a guarantee that expires before the thing it's guaranteeing has had a chance to happen — which is exactly what a 14-day or 30-day return window on a supplement like this really is.

That is where the risk belongs. On the company. Not on a 69-year-old woman on a fixed income who has already paid for four things that didn't work.

The Choice That Will Define Your Next Decade

I've been doing this long enough to know how this usually goes.

Some people will read every word of this and still not act. They'll tell themselves they'll think about it. They'll bookmark it. They'll close the tab and the tab will stay closed.

And a year from now they'll be exactly where they are tonight. Which, if you've had this for a while, you know is not a neutral outcome.

You're at a fork. Two roads.

Path 1: Change nothing.

Keep taking the drug whose own manufacturer-funded trial concluded it was “probably ineffective or only minimally effective” for exactly your condition. Keep paying for blocks that fade in days without touching the oxidative process underneath. Keep lying awake at 2 A.M. Keep hanging your feet off the bed. Keep being a recurring line item for an industry that does very well out of you not getting better.

Path 2: Try the thing that reaches the tissue.

Spend less than a co-pay. Get the active half of the molecule the German trials were built around, at the 600 mg those trials landed on, with nothing else in the pouch. Give it six honest weeks. Put the sheet back over your feet. Walk the whole grocery store. Stand up in the morning without deciding whether you can.

And if it doesn't happen, you're out nothing, because I've put the risk on us for a full 90 days.

I don't think that's a close call. But it's yours to make, and it's the one thing in this entire story nobody can bill you for.

Here's Exactly What To Do Next

  1. Click the green button below that says APPLY DISCOUNT & CHECK AVAILABILITY.
  2. Choose your package. Take at least the 90-day supply — not as an upsell, but because six weeks is where this declares itself and you do not want to run out in week five.
  3. Enter your shipping details.
  4. Take one softgel every evening. Every evening. The oxidative load is highest at the end of the day, and consistency is doing most of the work here.
  5. Write down what your nights are like in week one, so that in week four you have something honest to compare against. Almost everybody forgets how bad it was.
  6. If you're on insulin or another glucose-lowering medication, tell your doctor you've started it — R-ALA can affect blood sugar, and that's a conversation worth having up front.

And whatever you do, don't close this page telling yourself you'll come back to it.

Later is another night with the fan on. Later is another month of a pill that doesn't reach the problem. Later is the thing you've already tried for six years.

Your feet have waited long enough.

APPLY DISCOUNT & CHECK AVAILABILITY50% Off + Buy 1, Get 1 Free · 90-Day Guarantee

Pure R-form · 600 mg per serving · one ingredient.
Only available direct. 90-day money-back guarantee, empty pouch included. Free shipping.

With respect,Dr. Alan Voss, MD — Meridian Nerve Research

P.S. Delores sent me a photograph last month. She's standing barefoot on her kitchen tile, and her daughter has captioned it “Mom, standing on the floor. On purpose.” That photograph is the entire reason this page exists.

P.P.S. If you take one thing from all of this, take the R-versus-S distinction. Even if you never buy a thing from us: check the label of whatever alpha-lipoic acid you own right now. If it just says “alpha-lipoic acid” or “ALA” with no R, you have been taking a 50/50 blend, and roughly half of every capsule was the isomer your nerves can't use. That fact is free. I'd rather you knew it and bought someone else's pure R-form than didn't know it at all.

P.P.P.S. The 1999 conclusion, the $430 million settlement, the German approval and reimbursement, the SYDNEY 2 dose — every one of those is a matter of public record and I've listed the sources below. Go and read them. You have been asked to take things on faith for long enough.

References

  1. Gorson KC, et al. Gabapentin in the treatment of painful diabetic neuropathy. J Neurol Neurosurg Psychiatry 1999;66(2):251–252.
  2. U.S. Department of Justice press release #322, May 13, 2004 — Warner-Lambert guilty plea and $430 million resolution.
  3. In re Neurontin Marketing, Sales Practices and Products Liability Litigation, U.S. District Court, District of Massachusetts.
  4. Mijnhout GS, et al. Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes. Int J Endocrinol 2012. PMID 22331979.
  5. Ziegler D, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy (SYDNEY 2). Diabetes Care 2006;29:2365–2370.
  6. Ziegler D, et al. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid (ALADIN). Diabetologia 1995. PMID 8786016.
  7. Ziegler D, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years (NATHAN 1). Diabetes Care 2011;34:2054.
  8. Wiffen PJ, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2017;CD007938.
  9. Sloan G, et al. The ACCORD trial and diabetic peripheral neuropathy prevalence. Frontiers in Endocrinology, 2021.
  10. Breithaupt-Grögler K, et al. Pharmacokinetics of R- and S-alpha-lipoic acid.
  11. Steinman MA, et al. The Neurontin Legacy — Marketing through Misinformation and Manipulation. N Engl J Med 2009.
This is an advertisement and not an actual news article, blog, or consumer protection update. Dr. Alan Voss and Meridian Nerve Research are a composite presentation used for illustrative purposes. Patient names and quotations are illustrative; individual results vary and no outcome is typical or guaranteed. Court records, settlement figures, regulatory approvals and published trial citations referenced above are matters of public record and are listed in the references. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information on this page is for informational purposes only and is not a substitute for advice from your physician or other health care professional. Do not stop, start or change any prescribed medication without your physician's guidance. If you take insulin or another glucose-lowering medication, speak with your doctor before starting, as R-alpha lipoic acid may affect blood sugar. This page and its owner may receive compensation for purchases made through the links above.